Matthew S Davids (Matthew Davids)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 42

Top Topics

Locally Advanced

Chronic Lymphocytic Leukemia

Histone Deacetylase

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sigrid S Skånland, Klaus Okkenhaug, Matthew S Davids
PI3K Inhibitors in Hematology: When One Door Closes…. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Jennifer R Brown, Kiyomi Mashima, Stacey Fernandes, Aishath Naeem, Samantha Shupe, Rayan Fardoun, Matthew S Davids
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL. Research square (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology 99 (9) (2024)
Jennifer R Brown, Kiyomi Mashima, Stacey Fernandes, Aishath Naeem, Samantha Shupe, Rayan Fardoun, Matthew S Davids
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL. Research square (2024)
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker, Robert Black, Josie Montegaard, Alvaro J Alencar, Leyla Shune, Mohammad Omaira, Caron A Jacobson, Philippe Armand, Samuel Y Ng, Jennifer Crombie, David C Fisher, Ann Steward LaCasce, Jon Arnason, Ephraim P Hochberg, Ronald W Takvorian, Jeremy S Abramson, Jennifer R Brown, Matthew S Davids
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. Blood advances 8 (4) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker, Robert Black, Josie Montegaard, Alvaro J Alencar, Leyla Shune, Mohammad Omaira, Caron A Jacobson, Philippe Armand, Samuel Y Ng, Jennifer Crombie, David C Fisher, Ann Steward LaCasce, Jon Arnason, Ephraim P Hochberg, Ronald W Takvorian, Jeremy S Abramson, Jennifer R Brown, Matthew S Davids
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. Blood advances 8 (4) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Csaba Siffel, Joshua Richter, Colin Anderson-Smits, Marta Kamieniak, Kaili Ren, Drishti R Shah, Matthew S Davids
Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study. Annals of hematology (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Sigrid S Skånland, Klaus Okkenhaug, Matthew S Davids
PI3K inhibitors in hematology: When one door closes…. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Nehal J Lakhani, Drew W Rasco, Hengbang Wang, Lichuang Men, Eric Liang, Lei Tommy Fu, Mary C Collins, Ping Min, Yan Yin, Matthew S Davids, Dajun Yang, Yifan Zhai
First-in-Human Study with preclinical data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Julien Broseus, Sebastien Hergalant, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Daniel Rosebrock, Shanye Yin, Stephanie L Deng, Kara Slowik, Raquel Jacobs, Teddy Huang, Shuqiang Li, Geoffrey G Fell, Robert A Redd, Ziao Lin, Binyamin Asher Knisbacher, Dimitri Livitz, Christof Schneider, Neil Ruthen, Liudmila Elagina, Amaro Taylor-Weiner, Bria Persaud, Aina Z Martinez, Stacey M Fernandes, Noelia Purroy, Annabelle J Anandappa, Jialin Ma, Julian M Hess, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William G Wierda, Florence Cymbalista, Pierre Feugier, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S Neuberg, Matthew S Davids, Jennifer R Brown, Laxmi Parida, Stephan Stilgenbauer, Gad A Getz, Catherine J Wu
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine 29 (1) (2023)
Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Julien Broseus, Sebastien Hergalant, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Daniel Rosebrock, Shanye Yin, Stephanie L Deng, Kara Slowik, Raquel Jacobs, Teddy Huang, Shuqiang Li, Geoffrey G Fell, Robert A Redd, Ziao Lin, Binyamin Asher Knisbacher, Dimitri Livitz, Christof Schneider, Neil Ruthen, Liudmila Elagina, Amaro Taylor-Weiner, Bria Persaud, Aina Z Martinez, Stacey M Fernandes, Noelia Purroy, Annabelle J Anandappa, Jialin Ma, Julian M Hess, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William G Wierda, Florence Cymbalista, Pierre Feugier, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S Neuberg, Matthew S Davids, Jennifer R Brown, Laxmi Parida, Stephan Stilgenbauer, Gad A Getz, Catherine J Wu
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine 29 (1) (2023)
Othman Al-Sawaf, Matthew S Davids
Overcoming Resistance in Chronic Lymphocytic Leukemia - Maybe Less is More? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Julien Broseus, Sebastien Hergalant, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Daniel Rosebrock, Shanye Yin, Stephanie L Deng, Kara Slowik, Raquel Jacobs, Teddy Huang, Shuqiang Li, Geoffrey G Fell, Robert A Redd, Ziao Lin, Binyamin Asher Knisbacher, Dimitri Livitz, Christof Schneider, Neil Ruthen, Liudmila Elagina, Amaro Taylor-Weiner, Bria Persaud, Aina Z Martinez, Stacey M Fernandes, Noelia Purroy, Annabelle J Anandappa, Jialin Ma, Julian M Hess, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William G Wierda, Florence Cymbalista, Pierre Feugier, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S Neuberg, Matthew S Davids, Jennifer R Brown, Laxmi Parida, Stephan Stilgenbauer, Gad A Getz, Catherine J Wu
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine (2023)
Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Julien Broseus, Sebastien Hergalant, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Daniel Rosebrock, Shanye Yin, Stephanie L Deng, Kara Slowik, Raquel Jacobs, Teddy Huang, Shuqiang Li, Geoffrey G Fell, Robert A Redd, Ziao Lin, Binyamin Asher Knisbacher, Dimitri Livitz, Christof Schneider, Neil Ruthen, Liudmila Elagina, Amaro Taylor-Weiner, Bria Persaud, Aina Z Martinez, Stacey M Fernandes, Noelia Purroy, Annabelle J Anandappa, Jialin Ma, Julian M Hess, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William G Wierda, Florence Cymbalista, Pierre Feugier, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S Neuberg, Matthew S Davids, Jennifer R Brown, Laxmi Parida, Stephan Stilgenbauer, Gad A Getz, Catherine J Wu
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine 29 (1) (2023)
Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Julien Broseus, Sebastien Hergalant, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Daniel Rosebrock, Shanye Yin, Stephanie L Deng, Kara Slowik, Raquel Jacobs, Teddy Huang, Shuqiang Li, Geoffrey G Fell, Robert A Redd, Ziao Lin, Binyamin Asher Knisbacher, Dimitri Livitz, Christof Schneider, Neil Ruthen, Liudmila Elagina, Amaro Taylor-Weiner, Bria Persaud, Aina Z Martinez, Stacey M Fernandes, Noelia Purroy, Annabelle J Anandappa, Jialin Ma, Julian M Hess, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William G Wierda, Florence Cymbalista, Pierre Feugier, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S Neuberg, Matthew S Davids, Jennifer R Brown, Laxmi Parida, Stephan Stilgenbauer, Gad A Getz, Catherine J Wu
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nature medicine 29 (1) (2023)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Christine E Ryan, Matthew S Davids
Practical Management of Richter Transformation in 2023 and Beyond. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Sikandar Ailawadhi, Zi Chen, Bo Huang, Aneel Paulus, Mary C Collins, Lei Tommy Fu, Mingyu Li, Mohammad Ahmad, Lichuang Men, Hengbang Wang, Matthew S Davids, Eric Liang, Divya J Mekala, Zhicong He, Masa Lasica, Costas K Yannakou, Ricardo D Parrondo, Laura Glass, Dajun Yang, Asher A Chanan-Khan, Yifan Zhai
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Mary C Collins, Stacey M Fernandes, Yue Ren, Yinglu Zhou, Mikaela M McDonough, Heather A Walker, Monica R McEwan, Jeremy S Abramson, Eric D Jacobsen, Ann S LaCasce, David C Fisher, Jennifer R Brown, Matthew S Davids
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia. Leukemia (2023)
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C Fisher, Philippe Armand, Matthew S Davids, Scott Rodig, Barbara Sherry, Jennifer R Brown
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors. Blood cancer journal 13 (1) (2023)
Matthew S Davids
Functional cure reported in CLL. Blood 142 (21) (2023)
Alberto J Arribas, Eugenio Gaudio, Sara Napoli, Charles Jean Yvon Herbaux, Chiara Tarantelli, Roberta Pittau Bordone, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S Davids, Francesco Bertoni
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine. bioRxiv : the preprint server for biology (2023)
Christine E Ryan, Matthew S Davids, Richard Hermann, Mina Shahkarami, Juliana Biondo, Sarang Abhyankar, Hasan Alhasani, Jeff P Sharman, Anthony R Mato, Lindsey Elizabeth Roeker
MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. Future oncology (London, England) (2022)
Matthew S Davids, Mazyar Shadman, Sameer A Parikh, Chaitra S Ujjani, Jennifer L Crombie, Dingfeng Jiang, Cynthia Llamas, Dai Feng, Nicole Lamanna
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia. American journal of hematology 97 (3) (2022)
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, Gabriela Brunsting Hoffmann, Michaela Gruber, M Kendell Clement, Livius Penter, Robert A Redd, Neil Ruthen, Sebastien Hergalant, Alanna Sholokhova, Geoffrey G Fell, Erin M Parry, Julien Broseus, Romain Guieze, Jennifer A Woyach, María Hernández-Sánchez, Kaitlyn Baranowski, Jackson Southard, Heather Joyal, Leah Billington, Fara Faye D Regis, Elizabeth Witten, Mohamed Uduman, Binyamin Asher Knisbacher, Shuqiang Li, Haoxiang Lyu, Tiziana Vaisitti, Silvia Deaglio, Giorgio Ga Inghirami, Pierre Feugier, Stephan Stilgenbauer, Eugen Tausch, Matthew S Davids, Gad A Getz, Kenneth J Livak, Ivana Bozic, Donna S Neuberg, Ruben D Carrasco, Catherine J Wu
In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities. Blood cancer discovery (2022)
Deepti Gadi, Alec M Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander Vartanov, Emily M Thrash, Stacey M Fernandes, Timothy Z Lehmberg, Brandon Lee, Stephen P Martindale, John-Hanson Machado, Oreofe Odejide, Philippe Armand, David C Fisher, Jon Arnason, Matthew S Davids, James A Lederer, Jennifer R Brown
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia. Leukemia (2021)
Jorge J Castillo, John N Allan, Tanya Siddiqi, Ranjana H Advani, Kirsten Meid, Carly Leventoff, Timothy P White, Catherine A Flynn, Shayna R Sarosiek, Andrew R Branagan, Maria G Demos, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Christopher J Patterson, Zachary R Hunter, Matthew S Davids, Richard R Furman, Steven P Treon
Venetoclax in Previously Treated Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Relja Popovic, Fengjiao Dunbar, Charles Lu, Kenneth Robinson, Danjuma Quarless, Scott E Warder, Nabanita Mukherjee, John Pesko, Andrew J Souers, Jeffrey F Waring, Matthew S Davids, Eugen Tausch, Stephan Stilgenbauer, Jeremy A Ross, Joel D Leverson, Su Young Kim, Brenda J Chyla
Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy. American journal of hematology (2021)
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Stephen J F Chong, Mary C Collins, Rebecca Valentin, Liam Hackett, Olivier Tournilhac, François Lemonnier, Jehan Dupuis, Adrien Daniel, Cecile Tomowiak, Kamel Laribi, Richard Greil, Damien Roosweil, Cédric Rossi, Eric Van Den Neste, Cecile Leyronnas, Fatiha Merabet, Jean Valère Malfuson, Mourad Tiab, Loïc Ysebaert, Samuel Ng, Judith Trotman, Philipp B Staber, Matthew S Davids
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Blood 137 (25) (2021)
Matthew S Davids, David C Fisher, Svitlana Tyekucheva, Mikaela McDonough, John Hanna, Brandon Lee, Karen Francoeur, Josie Montegaard, Oreofe Odejide, Philippe Armand, Jon Arnason, Jennifer R Brown
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients. Leukemia 35 (4) (2020)